z-logo
open-access-imgOpen Access
Loss of Trex1 in Dendritic Cells Is Sufficient To Trigger Systemic Autoimmunity
Author(s) -
Katrin Peschke,
Martin Achleitner,
Kathrin Frenzel,
Alexander Gerbaulet,
Servi-Remzi Ada,
Nicolas Zeller,
Stefan Lienenklaus,
Mathias Lesche,
Claire Poulet,
Ronald Naumann,
Andreas Dahl,
Ursula Ravens,
Claudia Günther,
Werner Müller,
KlausPeter Knobeloch,
Marco Prinz,
Axel Roers,
Rayk Behrendt
Publication year - 2016
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.1600722
Subject(s) - autoimmunity , immunology , medicine , immune system
Defects of the intracellular enzyme 3' repair exonuclease 1 (Trex1) cause the rare autoimmune condition Aicardi-Goutières syndrome and are associated with systemic lupus erythematosus. Trex1(-/-) mice develop type I IFN-driven autoimmunity, resulting from activation of the cytoplasmic DNA sensor cyclic GMP-AMP synthase by a nucleic acid substrate of Trex1 that remains unknown. To identify cell types responsible for initiation of autoimmunity, we generated conditional Trex1 knockout mice. Loss of Trex1 in dendritic cells was sufficient to cause IFN release and autoimmunity, whereas Trex1-deficient keratinocytes and microglia produced IFN but did not induce inflammation. In contrast, B cells, cardiomyocytes, neurons, and astrocytes did not show any detectable response to the inactivation of Trex1. Thus, individual cell types differentially respond to the loss of Trex1, and Trex1 expression in dendritic cells is essential to prevent breakdown of self-tolerance ensuing from aberrant detection of endogenous DNA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom